Welcome to LookChem.com Sign In|Join Free
  • or
6-iodo-1-methyl-1H-benzo[d]imidazole is a chemical compound with the molecular formula C8H7IN2. It is a derivative of benzimidazole, a heterocyclic aromatic organic compound consisting of a benzene ring fused to an imidazole ring. The compound features a methyl group (-CH3) attached to the nitrogen atom at position 1 and an iodine atom (-I) at position 6 of the benzene ring. This halogenated benzimidazole is known for its potential applications in the synthesis of various pharmaceuticals and agrochemicals, as well as its use as an intermediate in the preparation of other organic compounds. Due to its unique structure and properties, 6-iodo-1-methyl-1H-benzo[d]imidazole has attracted interest in the field of medicinal chemistry for its potential biological activities and therapeutic applications.

705262-58-4

Post Buying Request

705262-58-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

705262-58-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 705262-58-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,5,2,6 and 2 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 705262-58:
(8*7)+(7*0)+(6*5)+(5*2)+(4*6)+(3*2)+(2*5)+(1*8)=144
144 % 10 = 4
So 705262-58-4 is a valid CAS Registry Number.

705262-58-4Downstream Products

705262-58-4Relevant academic research and scientific papers

INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES

-

Paragraph 00217-00218, (2021/12/30)

Provided herein are heteroaryl inhibitors of fibroblast growth factor receptor kinases, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

NOVEL COMPOUNDS AS PHARMACEUTICAL AGENTS

-

Page 47, (2010/02/07)

The current invention relates to compounds of the formula:(Ia) and the pharmaceutically acceptable salts thereof and their use as TGF-beta signal transduction inhibitors for treating cancer and other diseases in a patient in need thereof by administration of said compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 705262-58-4